{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:21:24Z","timestamp":1791177684250,"version":"4.1.0"},"reference-count":163,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Diabetes mellitus prevalence is rising worldwide, with a predicted 20% increase between 2021 and 2030, bringing an increased burden of complications such as diabetic retinopathy (DR). DR is a common and serious ocular complication of diabetes, and one of the most common irreversible blinding ophthalmic diseases. Its pathogenesis is intricate and complex, involving hypoxia, oxidative stress, inflammation, abnormalities in the polyol metabolic pathway, and others. Clinical detection of DR is impeded by atypical early symptoms, imperfect imaging screening tools, ocular comorbidities (e.g., cataract), and shortages of human resources. Therefore, more in-depth studies are needed to improve DR diagnosis and identify higher-risk patients. \u201cOmics\u201d encompasses genomics, transcriptomics, proteomics, and metabolomics. Omics technologies are increasingly used in research seeking to identify biomarkers or early preclinical signs of disease, or to better understand complex pathological processes determining disease prognosis. And DR is no exception, as an area in need of improved understanding and prognosis. To date, research has yielded significant results advancing DR diagnosis and treatment, informing prevention strategies and reducing global disease impact. This article reviewed recent findings of omics in DR diagnosis and treatment, improving our understanding of DR pathology and enabling personalized treatments.<\/jats:p>","DOI":"10.3389\/fendo.2025.1595207","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T05:22:57Z","timestamp":1751347377000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["New insights of potential biomarkers in diabetic retinopathy: integrated multi-omic analyses"],"prefix":"10.3389","volume":"16","author":[{"given":"Xurui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2337\/dci23-0085","article-title":"Economic costs of diabetes in the U.S. @ in 2022","volume":"47","author":"Parker","year":"2024","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S297494","article-title":"Diabetic retinopathy in the aging population: A perspective of pathogenesis and treatment","volume":"16","author":"Leley","year":"2021","journal-title":"CIA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v10.i3.140","article-title":"Cataract in diabetes mellitus","volume":"10","author":"Kiziltoprak","year":"2019","journal-title":"WJD"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/clinpract12040050","article-title":"Screening of diabetic retinopathy using teleophthalmology to complement human resources for eye health: A systematic review and meta-analysis","volume":"12","author":"Zikhali","year":"2022","journal-title":"Clinics Pract"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9836256","article-title":"Onco-multi-OMICS approach: A new frontier in cancer research","volume":"2018","author":"Chakraborty","year":"2018","journal-title":"BioMed Res Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12369","article-title":"Recent technological developments in proteomics shed new light on translational research on diabetic microangiopathy","volume":"280","author":"Ma","year":"2013","journal-title":"FEBS J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/tvst.7.5.12","article-title":"Personalized proteomics for precision health: identifying biomarkers of vitreoretinal disease","volume":"7","author":"Velez","year":"2018","journal-title":"Trans Vis Sci Tech"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1586\/14737159.6.4.575","article-title":"Metabolomic approaches to phenotype characterization and applications to complex diseases","volume":"6","author":"Ore\u0161i\u010d","year":"2006","journal-title":"Expert Rev Mol Diagnost"},{"key":"B12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.plipres.2014.06.001","article-title":"Systems biology strategies to study lipidomes in health and disease","volume":"55","author":"Hy\u00f6tyl\u00e4inen","year":"2014","journal-title":"Prog Lipid Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1186\/s12859-015-0857-9","article-title":"Methods for the integration of multi-omics data: mathematical aspects","volume":"17","author":"Bersanelli","year":"2016","journal-title":"BMC Bioinf"},{"key":"B14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13073-018-0564-z","article-title":"Integrative omics analyses broaden treatment targets in human cancer","volume":"10","author":"Sengupta","year":"2018","journal-title":"Genome Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.46.11.1829","article-title":"Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The diabetes control and complications trial research group","volume":"46","year":"1997","journal-title":"Diabetes"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1167\/iovs.07-1633","article-title":"Heritability of the severity of diabetic retinopathy: the FIND-eye study","volume":"49","author":"Arar","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11892-014-0515-z","article-title":"Genetics of diabetic retinopathy","volume":"14","author":"Cho","year":"2014","journal-title":"Curr Diabetes Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S94508","article-title":"Update on genetics and diabetic retinopathy","volume":"9","author":"Schwartz","year":"2015","journal-title":"OPTH"},{"key":"B19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11892-019-1186-6","article-title":"Genetics of diabetic retinopathy","volume":"19","author":"Han","year":"2019","journal-title":"Curr Diabetes Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"6998","DOI":"10.1073\/pnas.0800454105","article-title":"Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications","volume":"105","author":"Tong","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1093","article-title":"TCF7L2 variation and proliferative diabetic retinopathy","volume":"62","author":"Luo","year":"2013","journal-title":"Diabetes"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-016-4075-y","article-title":"Candidate gene studies of diabetic retinopathy in human","volume":"43","author":"Pri\u0161\u010d\u00e1kov\u00e1","year":"2016","journal-title":"Mol Biol Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-014-0172-8","article-title":"Human genetics of diabetic retinopathy","volume":"37","author":"Tang","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912019107","article-title":"Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC)","volume":"107","author":"Neale","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912702107","article-title":"Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration","volume":"107","author":"Chen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr270","article-title":"Common variants near FRK\/COL10A1 and VEGFA are associated with advanced age-related macular degeneration","volume":"20","author":"Yu","year":"2011","journal-title":"Hum Mol Genet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajhg.2011.11.029","article-title":"Five years of GWAS discovery","volume":"90","author":"Visscher","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1002921","DOI":"10.1371\/journal.pgen.1002921","article-title":"New susceptibility loci associated with kidney disease in type 1 diabetes","volume":"8","author":"Sandholm","year":"2012","journal-title":"PloS Genet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2383","article-title":"Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes","volume":"44","author":"Morris","year":"2012","journal-title":"Nat Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ng.2578","article-title":"Seven new loci associated with age-related macular degeneration","volume":"45","author":"Fritsche","year":"2013","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/861291","article-title":"Identification of Diabetic Retinopathy Genes through a Genome-Wide Association Study among Mexican-Americans from Starr County, Texas","volume":"2010","author":"Fu","year":"2010","journal-title":"J Ophthalmol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-8068","article-title":"Replication analysis for severe diabetic retinopathy","volume":"53","author":"Grassi","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr121","article-title":"Genome-wide meta-analysis for severe diabetic retinopathy","volume":"20","author":"Grassi","year":"2011","journal-title":"Hum Mol Genet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.07.020","article-title":"Genome-wide association study of diabetic retinopathy in a Taiwanese population","volume":"118","author":"Huang","year":"2011","journal-title":"Ophthalmology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt161","article-title":"Genome-wide association study in a Chinese population with diabetic retinopathy","volume":"22","author":"Sheu","year":"2013","journal-title":"Hum Mol Genet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e111715","DOI":"10.1371\/journal.pone.0111715","article-title":"A genome-wide association study for diabetic retinopathy in a Japanese population: potential association with a long intergenic non-coding RNA","volume":"9","author":"Awata","year":"2014","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3697-2","article-title":"Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 gene","volume":"58","author":"Burdon","year":"2015","journal-title":"Diabetologia"},{"key":"B38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12881-018-0587-8","article-title":"Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy","volume":"19","author":"Graham","year":"2018","journal-title":"BMC Med Genet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13769","article-title":"A genome-wide association study suggests new evidence for an association of the NADPH Oxidase 4 (NOX 4) gene with severe diabetic retinopathy in type 2 diabetes","volume":"96","author":"Meng","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/db18-0567","article-title":"Multiethnic genome-wide association study of diabetic retinopathy using liability threshold modeling of duration of diabetes and glycemic control","volume":"68","author":"Pollack","year":"2019","journal-title":"Diabetes"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddab044","article-title":"Genome-wide association studies identify two novel loci conferring susceptibility to diabetic retinopathy in Japanese patients with type 2 diabetes","volume":"30","author":"Imamura","year":"2021","journal-title":"Hum Mol Genet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00439-015-1624-8","article-title":"Exome-based case-control association study using extreme phenotype design reveals novel candidates with protective effect in diabetic retinopathy","volume":"135","author":"Shtir","year":"2016","journal-title":"Hum Genet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2017.03.007","article-title":"Whole exome sequencing identification of novel candidate genes in patients with proliferative diabetic retinopathy","volume":"139","author":"Ung","year":"2017","journal-title":"Vision Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1315","article-title":"mRNA-Seq whole-transcriptome analysis of a single cell","volume":"6","author":"Tang","year":"2009","journal-title":"Nat Methods"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.002","article-title":"Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets","volume":"161","author":"Macosko","year":"2015","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05218-0","article-title":"Single-cell transcriptome analysis of the Akimba mouse retina reveals cell-type-specific insights into the pathobiology of diabetic retinopathy","volume":"63","author":"Van Hove","year":"2020","journal-title":"Diabetologia"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e1751","DOI":"10.1002\/ctm2.1751","article-title":"Single-cell RNA sequencing in exploring the pathogenesis of diabetic retinopathy","volume":"14","author":"Zhang","year":"2024","journal-title":"Clin Trans Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e2023290118","DOI":"10.1073\/pnas.2023290118","article-title":"A specific RIP3+ subpopulation of microglia promotes retinopathy through a hypoxia-triggered necroptotic mechanism","volume":"118","author":"He","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2337\/db21-0551","article-title":"Single-cell transcriptomics reveals novel role of microglia in fibrovascular membrane of proliferative diabetic retinopathy","volume":"71","author":"Hu","year":"2022","journal-title":"Diabetes"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e160940","DOI":"10.1172\/jci.insight.160940","article-title":"Single-cell transcriptome analyses reveal microglia types associated with proliferative retinopathy","volume":"7","author":"Liu","year":"2022","journal-title":"JCI Insight"},{"key":"B51","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/jpm13010146","article-title":"Microglia-derived spp1 promotes pathological retinal neovascularization via activating endothelial Kit\/Akt\/mTOR signaling","volume":"13","author":"Bai","year":"2023","journal-title":"JPM"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.7150\/thno.84236","article-title":"Tsp-1+ microglia attenuate retinal neovascularization by maintaining the expression of Smad3 in endothelial cells through exosomes with decreased miR-27a-5p","volume":"13","author":"Luo","year":"2023","journal-title":"Theranostics"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.942768","article-title":"Integrated multi-omics reveals the activated retinal microglia with intracellular metabolic reprogramming contributes to inflammation in STZ-induced early diabetic retinopathy","volume":"13","author":"Lv","year":"2022","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"109145","DOI":"10.1016\/j.isci.2024.109145","article-title":"Microglia-endothelial cross-talk regulates diabetes-induced retinal vascular dysfunction through remodeling inflammatory microenvironment","volume":"27","author":"Ben","year":"2024","journal-title":"iScience"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.680947","article-title":"Single-cell transcriptome profiling reveals the suppressive role of retinal neurons in microglia activation under diabetes mellitus","volume":"9","author":"Xiao","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2337\/db23-0368","article-title":"Specialized retinal endothelial cells modulate blood-retina barrier in diabetic retinopathy","volume":"73","author":"Yao","year":"2024","journal-title":"Diabetes"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-020-01995-8","article-title":"RNA sequencing reveals BMP4 as a basis for the dual-target treatment of diabetic retinopathy","volume":"99","author":"Dong","year":"2021","journal-title":"J Mol Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.01.011","article-title":"Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition","volume":"33","author":"Crespo-Garcia","year":"2021","journal-title":"Cell Metab"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.7150\/thno.92909","article-title":"G protein subunit alpha i2\u2019s pivotal role in angiogenesis","volume":"14","author":"Bai","year":"2024","journal-title":"Theranostics"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.929118","article-title":"Long term high glucose exposure induces premature senescence in retinal endothelial cells","volume":"13","author":"Bertelli","year":"2022","journal-title":"Front Physiol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"112391","DOI":"10.1016\/j.exger.2024.112391","article-title":"p53 accelerates endothelial cell senescence in diabetic retinopathy by enhancing FoxO3a ubiquitylation and degradation via UBE2L6","volume":"188","author":"Cheng","year":"2024","journal-title":"Exp Gerontol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.7150\/thno.83532","article-title":"Single-cell RNA sequencing reveals a unique pericyte type associated with capillary dysfunction","volume":"13","author":"Xia","year":"2023","journal-title":"Theranostics"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.2337\/db20-0839","article-title":"Pathogenesis study based on high-throughput single-cell sequencing analysis reveals novel transcriptional landscape and heterogeneity of retinal cells in type 2 diabetic mice","volume":"70","author":"Niu","year":"2021","journal-title":"Diabetes"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2550-21.2022","article-title":"Progressively decreased HCN1 channels results in cone morphological defects in diabetic retinopathy","volume":"42","author":"Han","year":"2022","journal-title":"J Neurosci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","volume":"30","author":"Tang","year":"2011","journal-title":"Prog Retinal Eye Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"109003","DOI":"10.1016\/j.isci.2024.109003","article-title":"A single cell atlas of circulating immune cells involved in diabetic retinopathy","volume":"27","author":"Liao","year":"2024","journal-title":"iScience"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01187-9","article-title":"Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics","volume":"54","author":"Jagadeesh","year":"2022","journal-title":"Nat Genet"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e59980","DOI":"10.7554\/eLife.59980","article-title":"Integration of genomics and transcriptomics predicts diabetic retinopathy susceptibility genes","volume":"9","author":"Skol","year":"2020","journal-title":"eLife"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1700394","DOI":"10.1002\/pmic.201700394","article-title":"The human eye proteome project: Updates on an emerging proteome","volume":"18","author":"Ahmad","year":"2018","journal-title":"Proteomics"},{"key":"B70","article-title":"Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus","volume":"19","author":"Jain","year":"2013","journal-title":"Mol Vis"},{"key":"B71","article-title":"Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness","author":"Ozturk","year":"2009","journal-title":"Mol Vis"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00200","article-title":"Molecular markers of diabetic retinopathy: Potential screening tool of the future","volume":"7","author":"Pusparajah","year":"2016","journal-title":"Front Physiol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3980\/j.issn.2222-3959.2014.06.10","article-title":"Elevation of serum apelin-13 associated with proliferative diabetic retinopathy in type 2 diabetic patients","volume":"7","author":"Du","year":"2014","journal-title":"Int J Ophthalmol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s12009-007-0037-2","article-title":"Vascular endothelial growth factor level in the serum of diabetic patients with retinopathy","volume":"39","author":"Celebiler Cavusoglu","year":"2007","journal-title":"Ann Ophthalmol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2249","article-title":"Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy","volume":"92","author":"Ogata","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2014.08.004","article-title":"The predictive role of markers of inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetes","volume":"29","author":"Rajab","year":"2015","journal-title":"J Diabetes its Complicat"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/sj\/eye\/6700095","article-title":"Comparison of serum NO, TNF-\u03b1, IL-1\u03b2, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus","volume":"16","author":"Doganay","year":"2002","journal-title":"Eye"},{"key":"B78","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1167\/iovs.04-1057","article-title":"Serum inflammatory markers in diabetic retinopathy","volume":"46","author":"Meleth","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1167\/iovs.14-14864","article-title":"Elevated plasma pentraxin 3 levels are associated with development and progression of diabetic retinopathy in korean patients with type 2 diabetes mellitus","volume":"55","author":"Yang","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12640","article-title":"Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy","volume":"32","author":"Sasongko","year":"2015","journal-title":"Diabetes Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1021\/pr3012073","article-title":"Verification of multimarkers for detection of early stage diabetic retinopathy using multiple reaction monitoring","volume":"12","author":"Kim","year":"2013","journal-title":"J Proteome Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"279393","DOI":"10.1155\/2015\/279393","article-title":"Elevated serum levels of soluble TNF receptors and adhesion molecules are associated with diabetic retinopathy in patients with type-1 diabetes","volume":"2015","author":"Sharma","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3980\/j.issn.2222-3959.2011.06.08","article-title":"Proteomic analysis of human serum from diabetic retinopathy","volume":"4","author":"Liu","year":"2011","journal-title":"Int J Ophthalmol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2012.08.027","article-title":"Protease profiling of different biofluids in type 1 diabetes mellitus","volume":"45","author":"Caseiro","year":"2012","journal-title":"Clin Biochem"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/1522-2683(200105)22:9<1838::AID-ELPS1838>3.0.CO;2-7","article-title":"Two-dimensional analysis of tear protein patterns of diabetic patients","volume":"22","author":"Herber","year":"2001","journal-title":"Electrophoresis"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2012.04.053","article-title":"In-depth analysis of the human tear proteome","volume":"75","author":"Zhou","year":"2012","journal-title":"J Proteom"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1021\/pr0501970","article-title":"Characterization of human tear proteome using multiple proteomic analysis techniques","volume":"4","author":"Li","year":"2005","journal-title":"J Proteome Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"R72","DOI":"10.1186\/gb-2006-7-8-r72","article-title":"Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors","volume":"7","author":"de Souza","year":"2006","journal-title":"Genome Biol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2012.01.019","article-title":"Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy","volume":"75","author":"Cs\u0151sz","year":"2012","journal-title":"J Proteom"},{"key":"B90","article-title":"the levels of endothelin, neuron-specific enolase, and their autoantibodies in the serum and tear fluid of patients with type 2 diabetes mellitus","volume":"126","author":"Tsybikov","year":"2010","journal-title":"Vestn Oftalmol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2011.10.006","article-title":"Comparison of tear proteins between healthy and early diabetic retinopathy patients","volume":"45","author":"Kim","year":"2012","journal-title":"Clin Biochem"},{"key":"B92","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1258\/0004563021901748","article-title":"Apolipoprotein a-I concentration in tears in diabetic retinopathy","volume":"39","author":"Kawai","year":"2002","journal-title":"Ann Clin Biochem"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.11.011","article-title":"Serum and tear levels of nerve growth factor in diabetic retinopathy patients","volume":"145","author":"Park","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13167-016-0065-3","article-title":"Tear fluid biomarkers in ocular and systemic disease: Potential use for predictive, preventive and personalised medicine","volume":"7","author":"Hagan","year":"2016","journal-title":"EPMA J"},{"key":"B95","doi-asserted-by":"publisher","first-page":"623619","DOI":"10.1155\/2015\/623619","article-title":"Combined methods for diabetic retinopathy screening, using retina photographs and tear fluid proteomics biomarkers","volume":"2015","author":"Torok","year":"2015","journal-title":"J Diabetes Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2415-13-40","article-title":"Tear fluid proteomics multimarkers for diabetic retinopathy screening","volume":"13","author":"Torok","year":"2013","journal-title":"BMC Ophthalmol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1178641816686078","DOI":"10.1177\/1178641816686078","article-title":"Characterization of vitreous and aqueous proteome in humans with proliferative diabetic retinopathy and its clinical correlation","volume":"8","author":"Balaiya","year":"2017","journal-title":"Proteomics Insights"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2339-2","article-title":"Selenoproteins and oxidative stress-induced inflammatory tumorigenesis in the gut","volume":"74","author":"Barrett","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"B99","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pain.2012.07.031","article-title":"Promoter demethylation of cystathionine-\u03b2-synthetase gene contributes to inflammatory pain in rats","volume":"154","author":"Qi","year":"2013","journal-title":"Pain"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2011.12.006","article-title":"Proteomic analysis and identification of aqueous humor proteins with a pathophysiological role in diabetic retinopathy","volume":"75","author":"Chiang","year":"2012","journal-title":"J Proteom"},{"key":"B101","doi-asserted-by":"publisher","first-page":"148039","DOI":"10.1155\/2012\/148039","article-title":"Proteomic analyses of the vitreous humour","volume":"2012","author":"Angi","year":"2012","journal-title":"Mediators Inflamm"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e8158","DOI":"10.1371\/journal.pone.0008158","article-title":"Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases","volume":"4","author":"Yoshimura","year":"2009","journal-title":"PloS One"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0627-y","article-title":"Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy","volume":"50","author":"Garc\u00eda-Ram\u00edrez","year":"2007","journal-title":"Diabetologia"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.126.8.1076","article-title":"Elevation of apolipoprotein a-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients","volume":"126","author":"Sim\u00f3","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/tvst.10.6.3","article-title":"Comprehensive proteomic profiling of aqueous humor proteins in proliferative diabetic retinopathy","volume":"10","author":"Xiao","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12014-021-09328-8","article-title":"A validated analysis pipeline for mass spectrometry-based vitreous proteomics: New insights into proliferative diabetic retinopathy","volume":"18","author":"Weber","year":"2021","journal-title":"Clin Proteom"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.5b00900","article-title":"Quantitative proteomics analysis of vitreous humor from diabetic retinopathy patients","volume":"14","author":"Loukovaara","year":"2015","journal-title":"J Proteome Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-22345","article-title":"Vitreous fibronectin and fibrinogen expression increased in eyes with proliferative diabetic retinopathy after intravitreal anti-VEGF therapy","volume":"58","author":"Wei","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2014.13","article-title":"A review of anti-VEGF agents for proliferative diabetic retinopathy","volume":"28","author":"Osaadon","year":"2014","journal-title":"Eye (Lond)"},{"key":"B110","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12014-018-9187-z","article-title":"Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis","volume":"15","author":"Zou","year":"2018","journal-title":"Clin Proteom"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1039\/c0mb00341g","article-title":"Metabolomics study of diabetic retinopathy using gas chromatography-mass spectrometry: A comparison of stages and subtypes diagnosed by western and Chinese medicine","volume":"7","author":"Li","year":"2011","journal-title":"Mol Biosyst"},{"key":"B112","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11306-018-1383-3","article-title":"Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy","volume":"14","author":"Rhee","year":"2018","journal-title":"Metabolomics"},{"key":"B113","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1167\/iovs.19-27321","article-title":"Arginine and carnitine metabolites are altered in diabetic retinopathy","volume":"60","author":"Sumarriva","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.757088","article-title":"Plasma metabolomics reveals metabolic profiling for diabetic retinopathy and disease progression","volume":"12","author":"Sun","year":"2021","journal-title":"Front Endocrinol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2021.09.021","article-title":"Plasma arginine and citrulline are elevated in diabetic retinopathy","volume":"235","author":"Peters","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2011.01.025","article-title":"Correlations of six related pyrimidine metabolites and diabetic retinopathy in Chinese type 2 diabetic patients","volume":"412","author":"Xia","year":"2011","journal-title":"Clin Chim Acta"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.2337\/db15-0661","article-title":"Plasma metabonomic profiling of diabetic retinopathy","volume":"65","author":"Chen","year":"2016","journal-title":"Diabetes"},{"key":"B118","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12986-019-0358-3","article-title":"Plasma metabolomic profiling of proliferative diabetic retinopathy","volume":"16","author":"Zhu","year":"2019","journal-title":"Nutr Metab (Lond)"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.01.188","article-title":"Plasma metabolic profile reveals PGF2\u03b1 protecting against non-proliferative diabetic retinopathy in patients with type 2 diabetes","volume":"496","author":"Peng","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B120","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/jcm8060874","article-title":"1H nuclear magnetic resonance (NMR)-based cerebrospinal fluid and plasma metabolomic analysis in type 2 diabetic patients and risk prediction for diabetic microangiopathy","volume":"8","author":"Lin","year":"2019","journal-title":"J Clin Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/iovs.63.2.17","article-title":"Plasma and vitreous metabolomics profiling of proliferative diabetic retinopathy","volume":"63","author":"Wang","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3390\/pharmaceutics14122751","article-title":"Integrated analysis of metabolomics and lipidomics in plasma of T2DM patients with diabetic retinopathy","volume":"14","author":"Ding","year":"2022","journal-title":"Pharmaceutics"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3109\/13813455.2011.623705","article-title":"Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients","volume":"117","author":"Munipally","year":"2011","journal-title":"Arch Physiol Biochem"},{"key":"B124","doi-asserted-by":"publisher","first-page":"e0241365","DOI":"10.1371\/journal.pone.0241365","article-title":"Metabolomics profiles associated with diabetic retinopathy in type 2 diabetes patients","volume":"15","author":"Yun","year":"2020","journal-title":"PloS One"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.2337\/db20-0104","article-title":"Circulating metabolites and lipids are associated to diabetic retinopathy in individuals with type 1 diabetes","volume":"69","author":"Curovic","year":"2020","journal-title":"Diabetes"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e15123","DOI":"10.1016\/j.heliyon.2023.e15123","article-title":"Novel insights into the mechanisms of hard exudate in diabetic retinopathy: Findings of serum lipidomic and metabolomics profiling","volume":"9","author":"Shen","year":"2023","journal-title":"Heliyon"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2001714","DOI":"10.1002\/advs.202001714","article-title":"Multiplatform metabolomics reveals novel serum metabolite biomarkers in diabetic retinopathy subjects","volume":"7","author":"Xuan","year":"2020","journal-title":"Adv Sci"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.871291","article-title":"Serum untargeted metabolomics reveal potential biomarkers of progression of diabetic retinopathy in asians","volume":"9","author":"Wang","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B129","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/metabo11090614","article-title":"Novel serum and urinary metabolites associated with diabetic retinopathy in three asian cohorts","volume":"11","author":"Quek","year":"2021","journal-title":"Metabolites"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e001443","DOI":"10.1136\/bmjdrc-2020-001443","article-title":"Metabolomics-based multidimensional network biomarkers for diabetic retinopathy identification in patients with type 2 diabetes mellitus","volume":"9","author":"Zuo","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.822647","article-title":"High-coverage serum metabolomics reveals metabolic pathway dysregulation in diabetic retinopathy: A propensity score-matched study","volume":"9","author":"Guo","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B132","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1167\/iovs.10-5348","article-title":"Metabolic fingerprints of proliferative diabetic retinopathy: An1 H-NMR\u2013based metabonomic approach using vitreous humor","volume":"51","author":"Barba","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B133","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00592-019-01363-0","article-title":"Metabolomic profile of diabetic retinopathy: a GC-TOFMS-based approach using vitreous and aqueous humor","volume":"57","author":"Wang","year":"2020","journal-title":"Acta Diabetol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11306-015-0877-5","article-title":"Global metabolomics reveals metabolic dysregulation in ischemic retinopathy","volume":"12","author":"Paris","year":"2016","journal-title":"Metabolomics"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.8b00169","article-title":"Metabolomics analysis of human vitreous in diabetic retinopathy and rhegmatogenous retinal detachment","volume":"17","author":"Haines","year":"2018","journal-title":"J Proteome Res"},{"key":"B136","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00125-020-05309-y","article-title":"Vitreous metabolomics profiling of proliferative diabetic retinopathy","volume":"64","author":"Tomita","year":"2021","journal-title":"Diabetologia"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2019.06.013","article-title":"Metabolic characterization of diabetic retinopathy: An 1H-NMR-based metabolomic approach using human aqueous humor","author":"Jin","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"B138","doi-asserted-by":"publisher","first-page":"41984","DOI":"10.1038\/srep41984","article-title":"Metabolomic profiling of reactive persulfides and polysulfides in the aqueous and vitreous humors","volume":"7","author":"Kunikata","year":"2017","journal-title":"Sci Rep"},{"key":"B139","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/srep00076","article-title":"Differential macrophage polarization promotes tissue remodeling and repair in a model of ischemic retinopathy","volume":"1","author":"Marchetti","year":"2011","journal-title":"Sci Rep"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1002\/mas.21455","article-title":"Mass spectrometric based approaches in urine metabolomics and biomarker discovery","volume":"36","author":"Khamis","year":"2017","journal-title":"Mass Spectrom Rev"},{"key":"B141","doi-asserted-by":"publisher","first-page":"e4792","DOI":"10.1002\/bmc.4792","article-title":"Urine metabolomics study of bushen huoxue prescription on diabetic retinopathy rats by UPLC-Q-exactive orbitrap-MS","volume":"34","author":"Wang","year":"2020","journal-title":"BioMed Chromatogr"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.0c06445","article-title":"The effect of exogenous free n\u03f5-(carboxymethyl)lysine on diabetic-model goto-kakizaki rats: Metabolomics analysis in serum and urine","volume":"69","author":"Quan","year":"2021","journal-title":"J Agric Food Chem"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.930318","article-title":"Causal effects of gut microbiota on diabetic retinopathy: A mendelian randomization study","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.732204","article-title":"Gut microbiota composition and fecal metabolic profiling in patients with diabetic retinopathy","volume":"9","author":"Zhou","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.667632","article-title":"Alterations of the gut microbiome and metabolome in patients with proliferative diabetic retinopathy","volume":"12","author":"Ye","year":"2021","journal-title":"Front Microbiol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.757607","article-title":"In-depth molecular characterization of neovascular membranes suggests a role for hyalocyte-to-myofibroblast transdifferentiation in proliferative diabetic retinopathy","volume":"12","author":"Boneva","year":"2021","journal-title":"Front Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-023-01791-5","article-title":"Single-cell proteomics enabled by next-generation sequencing or mass spectrometry","volume":"20","author":"Bennett","year":"2023","journal-title":"Nat Methods"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202217","article-title":"Tandem mass tag-based proteomic analysis reveals cathepsin-mediated anti-autophagic and pro-apoptotic effects under proliferative diabetic retinopathy","volume":"13","author":"Niu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B149","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1186\/s12967-024-05654-1","article-title":"Indoxyl sulfate induces retinal microvascular injury via COX-2\/PGE2 activation in diabetic retinopathy","volume":"22","author":"Zhou","year":"2024","journal-title":"J Transl Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.830466","article-title":"Integration of metabolomics and proteomics in exploring the endothelial dysfunction mechanism induced by serum exosomes from diabetic retinopathy and diabetic nephropathy patients","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B151","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001158","article-title":"RETINAL VASCULAR CYSTOID MACULAR EDEMA: Review and new theory","volume":"36","author":"Spaide","year":"2016","journal-title":"Retina"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2015.08.006","article-title":"Analytical lipidomics in metabolic and clinical research","volume":"26","author":"Hy\u00f6tyl\u00e4inen","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-020-00759-4","article-title":"Omics research in diabetic kidney disease: new biomarker dimensions and new understandings","volume":"33","author":"Tofte","year":"2020","journal-title":"J Nephrol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.851967","article-title":"Expressions of serum lncRNAs in diabetic retinopathy \u2013 a potential diagnostic tool","volume":"13","author":"Biswas","year":"2022","journal-title":"Front Endocrinol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1523997","article-title":"Use of serum long non-coding RNA expression panel as a marker for diabetic retinopathy","volume":"12","author":"Wang","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B157","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1167\/tvst.13.12.23","article-title":"Multi-omics integration with machine learning identified early diabetic retinopathy, diabetic macula edema and anti-VEGF treatment response","volume":"13","author":"Pang","year":"2024","journal-title":"Trans Vis Sci Tech"},{"key":"B158","doi-asserted-by":"publisher","first-page":"167758","DOI":"10.1016\/j.bbadis.2025.167758","article-title":"Update in the molecular mechanism and biomarkers of diabetic retinopathy","volume":"1871","author":"Zhu","year":"2025","journal-title":"Biochim Biophys Acta (BBA)  Mol Basis Dis"},{"key":"B159","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.abj6987","article-title":"The complete sequence of a human genome","volume":"376","author":"Nurk","year":"2022","journal-title":"Science"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06457-y","article-title":"The complete sequence of a human Y chromosome","volume":"621","author":"Rhie","year":"2023","journal-title":"Nature"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05896-x","article-title":"A draft human pangenome reference","volume":"617","author":"Liao","year":"2023","journal-title":"Nature"},{"key":"B162","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13167-023-00313-9","article-title":"New insight of metabolomics in ocular diseases in the context of 3P medicine","volume":"14","author":"Zhang","year":"2023","journal-title":"EPMA J"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05285-y","article-title":"Intraocular fluid biomarkers (liquid biopsy) in human diabetic retinopathy","volume":"259","author":"Midena","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1595207\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T05:23:00Z","timestamp":1751347380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1595207\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":163,"alternative-id":["10.3389\/fendo.2025.1595207"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1595207","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"article-number":"1595207"}}